Instituto Nacional de Cancer

Rio de Janeiro, Rio de Janeiro Cep 2-0230

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Lung Cancer

Studies at this site

• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed